Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 619, Issue 1-2, 2007, Pages 104-112

  De Brakeleer, Sylvia ^a   Bogdani, Marika ^b   De Grève, Jacques ^a   Decock, Julie ^a   Sermijn, Erica ^a   Bonduelle, Maryse ^a   Goelen, Guido ^a   Teugels, Erik ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

BRCA1; BRCA2; Breast cancer; Immunocytochemistry

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENETIC DISORDER; GENOMIC INSTABILITY; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LEUKOCYTE; MALE; MUTATION; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; STAINING;

BRCA1 PROTEIN; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL NUCLEUS; DOWN-REGULATION; FEMALE; GENES, BRCA1; GENES, BRCA2; GENOMIC INSTABILITY; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES;

EID: 34247343751     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2007.02.031     Document Type: Article

References (36)

1. Merajver S.D., Frank T.S., Xu J., Pham T.M., Calzone K.A., Bennett-Baker P., Chamberlain J., Boyd J., Garber J.E., Collins F.S., and Weber B.L. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer. Clin. Cancer Res. 1 (1995) 539-544
2. Collins N., McManus R., Wooster R., Mangion J., Seal S., Lakhani S.R., Ormiston W., Daly P.A., Ford D., Easton D.F., and Stratton M.R. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 10 (1995) 1673-1675
3. Bogdani M., Teugels E., De Greve J., Bourgain C., Neyns B., and Pipeleers-Marichal M. Loss of nuclear BRCA1 localisation in breast carcinoma is age dependent. Virchows Arch. 440 (2002) 274-279
4. Chen Y., Chen C.F., Riley D.J., Allred D.C., Chen P.L., Von Hoff D., Osborne C.K., and Lee W.H. Aberrant subcellular localization of BRCA1 in breast cancer. Science 270 (1995) 789-791
5. Scully R., Ganesan S., Brown M., De Caprio J.A., Cannistra S.A., Feunteun J., Schnitt S., and Livingston D.M. Location of BRCA1 in human breast and ovarian cancer cells. Science 272 (1996) 123-125
6. Hogervorst F.B., Cornelis R.S., Bout M., van Vliet M., Oosterwijk J.C., Olmer R., Bakker B., Klijn J.G., Vasen H.F., Meijers-Heijboer H., Menko F.H., Cornelisse C.J., den Dunnen J.T., Devilee P., and van Ommen G.J.B. Rapid detection of BRCA1 mutations by the protein truncation test. Nat. Genet. 10 (1995) 208-212
7. van der Hout A.H., van den Ouweland A.M., van der Luijt R.B., Gille H.J., Bodmer D., Bruggenwirth H., Mulder I.M., van der Vlies P., Elfferich P., Huisman M.T., Ten Berge A.M., Kromosoeto J., Jansen R.P., van Zon P.H., Vriesman T., Arts N., Lange M.B., Oosterwijk J.C., Meijers-Heijboer H., Ausems M.G., Hoogerbrugge N., Verhoef S., Halley D.J., Vos Y.J., Hogervorst F., Ligtenberg M., and Hofstra R.M. A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting. Hum. Mutat. 27 (2006) 654-666
8. Chen Y., Farmer A.A., Chen C.F., Jones D.C., Chen P.L., and Lee W.H. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res. 56 (1996) 3168-3172
9. Jensen R., Thompson M., Jetton T., Szabo C., Van Der Meer R., Helow B., Tronick S., Page D., King M.C., and Holt J. BRCA1 is secreted and exhibits properties of a granin. Nat. Genet. 12 (1996) 303-308
10. Jarvis E.M., Kirk J.A., and Clarke C.L. Loss of nuclear BRCA1 expression in breast cancers is associated with a highly proliferative tumor phenotype. Cancer Genet. Cytogenet. 101 (1998) 109-115
11. Taylor J., Lymboura M., Pace P.E., Hern R.P., Desai A.J., and Shousha S. An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int. J. Cancer 79 (1998) 334-342
12. Bernard-Gallon D.J., Peffault De Latour M., Rio R.G., Penault-Llorca F.M., Favy D.A., Hizel C., Chassagne J., and Bignon Y.J. Subcellular localization of BRCA1 protein in sporadic breast carcinoma with or without allelic loss of BRCA1 gene. Int. J. Oncol. 14 (1999) 653-661
13. Lee W.Y., Jin Y.T., Chang T.W., and Su I.J. Immunolocalization of BRCA1 protein in normal breast tissue and sporadic breast carcinomas: a correlation with other biological parameters. Histopathology 34 (1999) 106-112
14. Wilson C.A., Payton M.N., Pekar S.K., Zhang K., Pacifici R.E., Gudas J.L., Thukral S., Calzone F.J., Reese D.M., and Slamon D.I. BRCA1 protein products: antibody specificity. Nat. Genet. 13 (1996) 264-265
15. Bernard-Gallon D.J., Crespin N.C., Maurizis J.C., and Bignon Y.J. Cross-reaction between antibodies raised against the last 20 C-terminal amino acids of BRCA1 (C-20) and human EGF and EGF-R in MCF 10a human mammary epithelial cell line. Int. J. Cancer 71 (1997) 123-126
16. Coene E., Van Oostveldt P., Willems K., van Emmelo J., and De Potter C.R. BRCA1 is localised in cytoplasmic tube like invaginations in the nucleus. Nat. Genet. 16 (1997) 122-124
17. Thakur S., Zhang H.B., Peng Y., Le H., Carroll B., Ward T., Yao J., Farid L.M., Couch F.J., Wilson R.B., and Weber B.L. Localization of BRCA1 and a splice site variant identifies the nuclear localisation signal. Mol. Cell. Biol. 17 (1997) 444-452
18. Wilson C.A., Payton M.N., Elliott G.S., Buaas F.W., Cajulis E.E., Grosshans D., Ramos L., Reese D.M., Slamon D.J., and Calzone F.J. Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11b. Oncogene 14 (1997) 1-16
19. Wang Y., Cortez D., Yazdi P., Neff N., Elledge S.J., and Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14 (2000) 927-939
20. Yoshikawa K., Honda K., Inamoto T., Shinohara H., Yamauchi A., Suga K., Okuyama T., Shimada T., Kodama H., Noguchi S., Gazdar A.F., Yamaoka Y., and Takahashi R. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases. Clin. Cancer. Res. 5 (1999) 1249-1260
21. Kainu T., Kononen J., Johansson O., Olsson H., Borg A., and Isola J. Detection of germline BRCA1 mutations in breast cancer patients by quantitative messenger RNA in situ hybridization. Cancer Res. 56 (1996) 2912-2915
22. Baldeyron C., Jacquemin E., Smith J., Jacquemont C., De Oliveira I., Gad S., Feunteun J., Stoppa-Lyonnet D., and Papadopoulo D. A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining. Oncogene 21 (2002) 1401-1410
23. Perrin-Vidoz L., Sinilnikova O.M., Stoppa-Lyonnet D.M., Lenoir G.M., and Mazoyer S. The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons. Hum. Mol. Genet. 11 (2002) 2805-2814
24. Li J., Zou C., Bai Y., Wazer D.E., Band V., and Gao Q. DSS1 is required for the stability of BRCA2. Oncogene 25 (2006) 1186-1194
25. Chen J., Silver D.P., Walpita D., Cantor S.B., Gazdar A.F., Tomlinson G., Couch F.J., Weber B.L., Ashley T., Livingston D.M., and Scully R. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol. Cell. 2 (1998) 317-328
26. Chen J., Silver D., Cantor S., Livingston D.M., and Scully R. BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway. Cancer Res. 59 (1999) 1752s-1756s
27. Haber J.E. Partners and pathways repairing a double-strand break. Trends Genet. 16 (2000) 259-264
28. Welcsh P.L., Owens K.N., and King M.C. Insights into the functions of BRCA1 and BRCA2. Trends Genet. 16 (2000) 69-74
29. Jasin M. Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Oncogene 21 (2002) 8981-8993
30. Tutt A., and Ashworth A. The relationship between the roles of BRCA genes in DNA repair and cancer predisposition. Trends Mol. Med. 8 (2002) 571-576
31. Venkitaraman A.R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108 (2002) 171-182
32. Foray N., Randrianarison V., Marot D., Perricaudet M., Lenoir G., and Feunteun J. Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene 18 (1999) 7334-7342
33. Rothfuss A., Schutz P., Bochum S., Volm T., Eberhardt E., Kreienberg R., Vogel W., and Speit G. Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res. 60 (2000) 390-394
34. Buchholz T.A., Wu X., Hussain A., Tucker S.L., Mills G.B., Haffty B., Bergh S., Story M., Geara F.B., and Brock W.A. Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2. Int. J. Cancer 97 (2002) 557-561
35. Trenz K., Rothfuss A., Schutz P., and Speit G. Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutation. Mutat. Res. 500 (2002) 89-96
36. Chenevix-Trench G., Spurdle A.B., Gatei M., Kelly H., Marsh A., Chen X., Donn K., Cummings M., Nyholt D., Jenkins M.A., Scott C., Pupo G.M., Dork T., Bendix R., Kirk J., Tucker K., McCredie M.R.E., Hopper J.L., Sambrook J., Mann G.J., and Kanna K.K. Dominant negative ATM mutations in breast cancer families. J. Natl. Cancer Inst. 94 (2002) 205-215